Posted by ed_uk on October 19, 2006, at 15:43:43
In reply to Long-acting quetiapine (Seroquel SR) filed for...., posted by ed_uk on October 19, 2006, at 15:40:04
......this happened a while ago in the US.
AstraZeneca says.....
18 July 2006
AstraZeneca Submits an NDA For Sustained Release Formulation SEROQUEL SR(TM) For the Treatment of SchizophreniaAstraZeneca today announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration for a sustained release (SR) once-daily formulation of SEROQUEL for the treatment of patients with schizophrenia. The clinical trials to support the US submission of SEROQUEL SRTM used a short titration period aimed at achieving a therapeutically effective dose by the second day of treatment. The Company also expects to make a SEROQUEL SR filing in the European Union towards the end of 2006. The SR formulation has patent protection to 2017.
poster:ed_uk
thread:696107
URL: http://www.dr-bob.org/babble/20061011/msgs/696108.html